BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Search the Site
 
   
Biotechnology and Pharmaceutical Channel Medical Device and Diagnostics Channel Clinical Research Channel BioSpace Collaborative    Job Seekers:  Register | Login          Employers:  Register | Login  

NEWSLETTERS
Free Newsletters
Archive
My Subscriptions

NEWS
News by Subject
News by Disease
News by Date
PLoS
Search News
Post Your News
JoVE

CAREER NETWORK
Job Seeker Login
Most Recent Jobs
Browse Biotech Jobs
Search Jobs
Post Resume
Career Fairs
Career Resources
For Employers

HOTBEDS
Regional News
US & Canada
  Biotech Bay
  Biotech Beach
  Genetown
  Pharm Country
  BioCapital
  BioMidwest
  Bio NC
  BioForest
  Southern Pharm
  BioCanada East
  US Device
Europe
Asia

DIVERSITY

INVESTOR
Market Summary
News
IPOs

PROFILES
Company Profiles

START UPS
Companies
Events

INTELLIGENCE
Research Store

INDUSTRY EVENTS
Biotech Events
Post an Event
RESOURCES
Real Estate
Business Opportunities

 News | News By Subject | News by Disease News By Date | Search News
eNewsletter Signup
Miles
Km80.5

   

Scientific Digital Imaging plc Acquires Opus Instruments Limited


2/14/2014 8:43:21 AM

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

February 14, 2014 -- The Board of Scientific Digital Imaging plc, the AIM quoted group focused on the application of digital imaging technology to the needs of the scientific community, announces the acquisition of Opus Instruments Limited (“Opus”) from its founder shareholders for consideration of up to £1,325,000 payable in cash and shares.

Opus is the manufacturer of the Osiris camera which the Board of SDI believes is the first camera for infrared reflectography to provide high resolution high speed images in a small portable camera. The Osiris cameras have been used predominately in art galleries and museums around the world to examine numerous works of art including work by artists such as Leonardo da Vinci, Rembrandt and Watteau. The Board of SDI believes that the Osiris cameras will enhance SDI’s current product offering and intends to explore further applications for the technology beyond its current use.

SDI will pay up to £1,325,000 for the acquisition of Opus, which consists of (i) initial consideration of in the region of £1,025,000, and (ii) deferred payments of up to a further £300,000 depending on the revenues received by the Company from the sale of Osiris cameras in the three years following the acquisition. The initial consideration comprises a cash payment of £275,000 on completion (funded by a new bank facility), a further payment of in the region of £300,000 shortly after completion (depending on the net assets of Opus at completion), and the issue of 2,601,156 new SDI ordinary shares (the “Consideration Shares”). The Consideration Shares have a value of £450,000 based on the average of the five most recent daily mid market closing prices calculated at the close of business on 11 February 2014. The further cash payments of up to £300,000 will be payable in quarterly instalments, based on quarterly sales. Laurence Robinson, one of the founders of Opus, will continue to provide consultancy services to Opus following completion.

Based in Bassingbourn, near SDI’s head office in Cambridge, Opus achieved sales of £293,000 (unaudited) and post-tax profits of £94,000 (unaudited) in each case for the 12 month period ending 30 April 2013. Opus had net assets as at 30 April 2013 of £82,000 (unaudited). The acquisition of Opus is expected to be earnings enhancing for SDI from the full year commencing 1 May 2014.

To facilitate the acquisition of Opus, SDI has entered into a software licence with Silfensoft Limited in relation to certain software required to operate the Osiris cameras. The consideration for the software licence consists of a payment in cash of £25,000, and the issue of 141,242 new SDI ordinary shares (the “Silfensoft Shares”).

Ken Ford, Chairman of SDI, commented: “This is an exciting acquisition for SDI and we plan to explore further applications for the infrared imaging system beyond art restoration. We believe that the Osiris camera unit will complement SDI’s existing portfolio of high specification and performance Atik and Artemis cameras and we expect it to be earnings enhancing in the next financial year.”

Separately, a former employee of the Company has exercised share options and the Company has issued 28,000 new SDI ordinary shares (the “Option Shares”).

Application will be made for admission of the Consideration Shares, the Silfensoft Shares and the Option Shares to trading on the AIM market of the London Stock Exchange and admission is expected to occur on 19 February 2014. Following admission, the total number of issued ordinary shares in the Company will be 27,805,308. The Company does not hold any ordinary shares in treasury and therefore this figure may be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the share capital of the Company under the Financial Conduct Authority's Disclosure and Transparency Rules.

For further information please contact:

Scientific Digital Imaging plc
Ken Ford, Chairman
Mike Creedon, Chief Executive Officer
+44 1223 727144

finnCap
Ed Frisby/Ben Thompson - Corporate Finance
Simon Starr - Corporate Broking +44 20 7220 0500

JW Communications
Julia Wilson - Investor & Public Relations +44 781 8430877
Scientific Digital Imaging Plc

Scientific Digital Imaging plc (SDI) is focused on the application of digital imaging technology to the needs of the scientific and technology community. Its principal subsidiary is Synoptics Limited, which designs and manufactures special-purpose instruments for use mainly in the life sciences, supplying customers in the academic, research and health sectors. Within Synoptics, the recently formed Synoptics Health division has launched the Synoptics Health ProReveal system. This patented system offers a highly sensitive fluorescence-based test to detect dirty surgical instruments in hospitals and aims to reduce incidences of cross contamination of patients. In addition, under the Atik brand, SDI designs and manufactures high-sensitivity cameras for both astronomical and life science applications.

www.scientificdigitalimaging.com

Osiris Infrared Imaging System

Osiris is the first infrared imaging system designed specifically for art conservators to provide high-resolution, high-speed images in a small portable camera. Osiris has been used to examine hundreds of works of art at many of the major national art galleries throughout the world. In the Louvre, works by artists such as Leonardo da Vinci, Rembrandt, Watteau have been examined. An ARM® microcontroller sits at the heart of the camera controlling the scanning system, driving the infrared sensor and sending the captured data to the PC over a USB connection. The PC receives the data stream and assembles it into an image of the under drawing, displaying it as the scanning process proceeds. The Board of SDI believes that the Osiris cameras will enhance SDI’s current product offering and intends to explore further applications for the technology beyond its current use.

Help employers find you! Check out all the jobs and post your resume.


Read at BioSpace.com

   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES